Healthcare consumers may be the driving force behind Health 2.0, but are they really in control? And who knows what the final destination will be?
By Bradley Schmidt
Advertisement
Articles by By Bradley Schmidt
Advertisement
Latest Updated Articles
- Where Do We Go from Here? A Health 2.0 Progress Report
January 19th 2009
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer
2
FDA Clears TumorSight Risk, an MRI-Derived AI Recurrence Tool for HR+, HER2– Breast Cancer
3
Vilamakitug Meets OS Threshold in Phase 1/2 Refractory mCRC Trial
4
Dr Cercek on the FDA Approval of Dostarlimab for dMMR/MSI-H Locally Advanced Rectal Cancer
5